LATEST NEWS

Terumo Blood and Cell Technologies Receives $10.6M Contract From U.S. Government to Continue Freeze-Dried Plasma Development

Antoinette Gawin is the only female and non-Japanese member in an important new Terumo Corporation GMEO role.

Terumo Blood and Cell Technologies Appoints Gene Stellon to Lead Innovation and Development

Queen’s University Belfast and Terumo Blood and Cell Technologies collaborate in Knowledge Transfer Partnership to develop next generation pharmaceutical packaging

U.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technology

Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe

Terumo Blood and Cell Technologies Opens Manufacturing Facility in Costa Rica

Terumo Blood and Cell Technologies is collaborating with BioCentriq to provide technologies and expertise to automate cell and gene therapy manufacturing

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare

Terumo Blood and Cell Technologies announces a new software update for its Finia^® Fill and Finish System as the cell and gene therapy industry evolves toward automation

Terumo Blood and Cell Technologies and PhotonPharma, Inc. announce collaboration to develop a novel cancer immunotherapy

Peer-reviewed study in Africa Sanguine shows positive health economic impact and reduced maternal mortality rate for countries investing in blood transfusion to save lives of African mothers

The Spectra Optia® Apheresis System from Terumo Blood and Cell Technologies in combination with UVA PIT System can now be used to provide extracorporeal photopheresis immunotherapy

Terumo Blood and Cell Technologies Joins Cell and Gene Therapy Catapult Process Analytical Technology (PAT) Consortium